Short description
ANGECON is a biotechnology company that develops cell drugs and healthy cell storage.
Description
ANGECON performs cell development, manufacturing, sales, warehousing, and service. They create new cell medicines and offer a variety of cell treatments to people suffering from long-term conditions of the central nervous system. They have established a base for cell production demonstration using their cell technologies, including cell separation and purification, culture and expansion, cryopreservation and recovery, directional induction, identification, and testing.
Last funding
Blurry Noaccess
Sign in for full access
Total funding
$$3123123
Sign in for full access
Location
Shanghai, Shanghai, China, Asia
Founded on
February 2, 2010
Exited on
October 23, 2015
Went public on
October 23, 2015
Stock symbol
833926
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$7890 - 12340
Sign in for full access
Investors
Noway Youcantaccess, Uh Ohhhh
Sign in for full access
Founders
Jin Yiqiang